Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 186, Issue 1-2, Pages 181-192Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2007.03.023
Keywords
Alzheimer's disease; dementia; neuroimmune markers; A beta((25-35)) oligomers; protein s100b; neurotransmitters
Categories
Ask authors/readers for more resources
Alzheimer's disease (AD) autoimmunity is a focus for dementia prevention. Generated autoantibodies against major etiopathogenic molecular targets as neuroimmune markers of dementia were measured by ELISA in patient sera. Biphasic antibody levels to A beta((25-35)) oligomers, S100b and DA were detected during distinctly diagnosed dementia stages. A beta((25-35)) oligomer autoimmune responses reflected mild to moderate AD dementia, while those to S100b, DA and the S100b concentrations, matched moderate to severe dementia progression. 5-HT antibodies increased during mild dementia and plateaued thereafter. This autoimmunity pattern may be used as a differential biomarker profile in designing AD therapeutic strategies involving early vaccination. (c) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available